International neurosurgical expertise from China

Professor Donglei Song

A senior cerebrovascular neurosurgeon and neurointervention specialist with extensive experience in complex brain and spinal surgery, aneurysm treatment, AVM embolization, and integrated microsurgical and endovascular decision-making.

Clinical Philosophy

Choosing the right path matters as much as mastering the technique.

Professor Song combines open microsurgical neurosurgery with endovascular neurointervention, supporting treatment planning across multiple options for complex cerebrovascular disease.

Neurosurgical Focus

Specialized care for complex brain and vascular conditions.

Professor Song focuses on complex cerebrovascular disease and advanced neurosurgical decision-making, combining open microsurgery, endovascular intervention, and long-term patient-safety planning for selected cases.

01

Cerebral aneurysms

Selection between microsurgical clipping, endovascular embolization, flow diversion, and hybrid strategies based on anatomy, rupture risk, patient condition, and long-term safety.

02

Brain AVMs and dural AVFs

Advanced assessment and treatment of arteriovenous malformations and fistulas, including Onyx embolization experience and microsurgical planning.

03

Brain and spinal tumors

Microsurgical management of brain tumors and spinal cord tumors, supported by decades of operative neurosurgical experience.

04

Ischemic cerebrovascular disease

Evaluation of carotid stenosis, intracranial arterial stenosis, cerebral ischemia, and surgical or interventional options for selected patients.

05

Trauma and complex neurosurgery

Long-standing clinical experience in craniocerebral trauma and complex cranial and spinal operations.

Professor Donglei Song consulting with a patient and clinical colleague
Academic Profile

From Huashan Hospital training to a dedicated brain specialty group.

Professor Donglei Song graduated from Shanghai Medical University in 1990 and trained in neurosurgery at Huashan Hospital, Fudan University, under Professor Liangfu Zhou. He received his clinical medical doctorate in 1998, became Chief Physician at Huashan Hospital in 2005, and was approved as Professor and doctoral supervisor in 2007.

Before 2013, he served as Chief Physician, Professor, doctoral supervisor, and head of the cerebrovascular disease medical group in Huashan Hospital Neurosurgery. Since 2013, he has held leadership roles at Shanghai Deji Hospital, including President, Academic President, and Director of the Cerebrovascular Disease Diagnosis and Treatment Center. In 2015, he founded the Donglei Brain Doctor Group.

His clinical practice combines microsurgical operating capability with neurointerventional technology for difficult brain and spinal vascular disease.

International Standing

International exchange, training, and academic contribution.

Professor Song has trained and exchanged in France, the United States, Canada, Korea, Turkey, Brazil, Germany, Australia, Thailand, and other regions, and has delivered invited lectures at major international neurointerventional meetings.

30+SCI-indexed publications in international peer-reviewed journals
100+papers in Chinese core journals as first or corresponding author
Multiplenational and Shanghai science and medical technology awards
20+ yearsnational continuing education courses in cerebrovascular surgery
Professor Donglei Song speaking at a cerebrovascular academic conference
Hospital Leadership & Public Education

Building a brain-specialty platform beyond individual surgery.

In 2015, Professor Song founded Donglei Brain Doctor Group. In 2019, he led the establishment of Shanghai Donglei Brain Hospital and served as its president, with the first phase opening 100 beds and strategic cooperation with major brain-specialty and international medical-zone institutions.

In 2021, the hospital's annual surgical volume exceeded 2,000 cases, establishing it as a high-volume center for specialized neurosurgery. The same year, he helped initiate the Song Donglei Brain Research and Development Fund under the Shanghai Jiao Tong University Education Development Foundation to support advanced clinical research.

In 2024, he was selected for the National Health Science Popularization Expert Database and expanded public-facing medical education through multimedia digital platforms. In 2025, he delivered a keynote report at the Huanhu International Cerebrovascular Disease Conference. In 2026, he continued dementia-related public education and signed a strategic cooperation with Neusoft Medical.

Research & Education

Clinical science, surgical education, and standards of care.

National research participation

Participated in National Natural Science Foundation projects, Shanghai major research programs, clinical medicine center initiatives, and national technology-support studies on aneurysm, subarachnoid hemorrhage, cerebral ischemia, and AVM treatment.

Textbook and handbook contribution

Contributed to neurosurgery, neurology, endovascular neurosurgery, interventional neuroradiology, and DSA diagnosis textbooks and professional monographs.

Professional education platform

Since 2003, he has regularly organized national continuing education programs on cerebrovascular surgery, interventional treatment, and new neurosurgical technologies.

Clinical public recognition

Reported honors include selection to the 2012 China Top Doctors list, nomination for Shanghai's first Medical Ethics Model award, and the 2014 Qipu Award for innovation in physician services in China's health industry.

Brain Library

Cerebral aneurysms, brain AVMs, neurointervention, and microsurgery.

View Brain Library
Career Milestones

A timeline of surgical, academic, and international development.

  1. Graduated from Shanghai Medical University and began neurosurgical training at Huashan Hospital.

  2. Received a doctorate in clinical medicine under Professor Liangfu Zhou.

  3. Promoted to Chief Physician in Neurosurgery at Huashan Hospital, Fudan University.

  4. Approved as Professor and doctoral supervisor; received Shanghai Science and Technology Progress First Prize.

  5. Invited to LINNC Paris to present on the status of interventional treatment for brain AVMs in China.

  6. Founded Donglei Brain Doctor Group and became among the first Chinese trainers for Pipeline flow diverter technology.

  7. Led the establishment of Shanghai Donglei Brain Hospital and served as president.

  8. Exceeded 2,000 annual hospital surgeries and initiated the Song Donglei Brain Research and Development Fund.

  9. Expanded national health-science communication, conference education, outpatient services, and medical-technology cooperation.

For International Patients & Physicians

Structured review for complex neurosurgical decisions.

For international patients seeking consultation or treatment information.

Email consultation
Medical consultationTreatment consultationInternational patient inquiry